Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Other Accumulated Expenses (2020 - 2025)

Treace Medical Concepts' Other Accumulated Expenses history spans 6 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Other Accumulated Expenses rose 6.18% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, up 6.18%, while the annual FY2025 figure was $2.2 million, 6.18% up from the prior year.
  • Other Accumulated Expenses reached $2.2 million in Q4 2025 per TMCI's latest filing, down from $2.5 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $4.5 million in Q1 2024 to a low of $1.1 million in Q4 2021.
  • Average Other Accumulated Expenses over 5 years is $2.8 million, with a median of $2.8 million recorded in 2025.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 144.9% in 2021, then plummeted 48.24% in 2024.
  • A 5-year view of Other Accumulated Expenses shows it stood at $1.1 million in 2021, then skyrocketed by 64.63% to $1.8 million in 2022, then surged by 123.4% to $4.0 million in 2023, then plummeted by 48.24% to $2.1 million in 2024, then rose by 6.18% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Other Accumulated Expenses are $2.2 million (Q4 2025), $2.5 million (Q3 2025), and $2.8 million (Q2 2025).